Tag Archives: government

Obesity – a big problem but a shared responsibility

Guest Blog by Robin Millar, Acting Chief Executive, 2020health Obesity is a complex issue – like health itself, it affects how we live our daily lives, the environment in which we live and work and how we feel about ourselves. In … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

How can A&E units improve their performance?

The first point that I must make is that I do not wish to appear unappreciative or condescending. Hospital A&E work is amongst the most important that any person can undertake and many of us would find the strain unbearable. … Continue reading

Posted in A&E, Department of Health, Elderly, GPs, Hospitals, NHS, Patients | Tagged , , , , , , , , , , , , , ,

Dropped from Queen’s speech: would laws to ‘protect older people’ have made any difference?

I’ve just been speaking to @nickferrari on #LBC (7.50am) about the Government dropping plans for new laws in the Queen’s Speech to ‘prevent the abuse of older people by care staff’ as reported by @jameskirkikup. What is at the heart … Continue reading

Posted in Elderly | Tagged , , , , , , , | Leave a comment

Medical advisory body “NICE” should not spend too much time valuing drugs.

The UK National Institute for Health and Care Excellence (“NICE”) is currently holding a public consultation over its proposals for evaluating drugs. Drugs that are approved by NICE automatically become available for doctors to prescribe under the NHS throughout England … Continue reading

Posted in Business, CCGs, Commissioning, Department of Health, Drugs, Elderly, equality, Genetics, GPs, Health and Wellbeing, Health Bill, Health reform, Inequality, Innovation, Jeremy Hunt, NHS, NHS reforms, Patients, Pharma, Policy, Public Health, Research, Technology, Uncategorized, Wellbeing | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot: Negotiations with the UK Government over pharmaceutical pricing have achieved a good result for patients, the NHS and the industry.

The UK Government and the pharmaceutical industry shared many objectives throughout the recent drug pricing negotiations. For example, there was always broad agreement that: The total future drug bill needed to be affordable in the context of other spending in … Continue reading

Posted in Andrew Lansley, Business, Cancer, Department of Health, Drugs, Innovation, Jeremy Hunt, NHS, Patients, Pharma, Research, Smoking ban | Tagged , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Bad for patients and bad for growth?

2020health today publish a review from a patient’s perspective of the Government’s plans to change the way medicines are priced. Featured in today’s FT (£) we point out that patients are usually blissfully unaware of pricing negotiations but the Government’s … Continue reading

Posted in Innovation, Patients | Tagged , , , , , , , , , , | Leave a comment

Guest Blogspot: Waiting for Decisions on UK Pharmaceutical Pricing

Little has been heard over how confidential talks between the Government and the pharmaceutical industry are progressing towards the goal of having a new, voluntary UK drug pricing system in place in 2014. In the eyes of the pharmaceutical companies … Continue reading

Posted in Andrew Lansley, Business, Children, Commissioning, David Cameron, Department of Health, Drugs, Emerging technologies, equality, Health and Wellbeing, Innovation, Jeremy Hunt, Uncategorized, Wellbeing | Tagged , , , , , , , , , , , , | 1 Comment